首页> 外文期刊>Bone marrow transplantation >Efficacy and safety of keratinocyte growth factor (palifermin) for prevention of oral mucositis in TBI-based allogeneic hematopoietic stem cell transplantation.
【24h】

Efficacy and safety of keratinocyte growth factor (palifermin) for prevention of oral mucositis in TBI-based allogeneic hematopoietic stem cell transplantation.

机译:角质形成细胞生长因子(Palifermin)预防TBI基因造血干细胞移植中口腔粘膜炎的疗效和安全性。

获取原文
获取原文并翻译 | 示例
       

著录项

  • 来源
    《Bone marrow transplantation》 |2018年第9期|共5页
  • 作者单位

    Department of Haematology and Medical Oncology Clinic of Internal Medicine II University Hospital;

    Department of Haematology Oncology and Hemostaseology University Clinical Center University of;

    Department of Haematology and Medical Oncology Clinic of Internal Medicine II University Hospital;

    Department of Haematology Oncology and Hemostaseology University Clinical Center University of;

    Department of Haematology and Medical Oncology Clinic of Internal Medicine II University Hospital;

    Department of Haematology Oncology and Hemostaseology University Clinical Center University of;

    WiSP Wissenschaftlicher Service Pharma GmbH Langenfeld Germany;

    Department of Bone Marrow Transplantation West German Cancer Center Faculty of Medicine;

    Department of Haematology Oncology Palliative Care University of Rostock Rostock Germany;

    Department of Hematology Oncology and Tumorimmunology Charité - Universit?tsmedizin Berlin;

    Internal Medicine C (Hematology and Oncology Palliative Care Transplant Centre) University;

    Department of Haematology and Medical Oncology Clinic of Internal Medicine II University Hospital;

    Department of Haematology and Medical Oncology Clinic of Internal Medicine II University Hospital;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 治疗学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号